Showing results (471-480 of 1,403) with videos related to
Sort By:
Pageof 141
Metabolic Syndrome and Related Disorders|October 21, 2010
ENPP1/PC-1 K121Q and other predictors of posttransplant diabetesMagdalene Szuszkiewicz, Jason Bell, Miguel Vazquez, et al.Metabolic Syndrome and Related Disorders|February 22, 2011
Resistin is an indicator of the metabolic syndrome according to five different definitions in the Finnish Health 2000 surveyElina Malo, Olavi Ukkola, Maarit Jokela, et al.Metabolic Syndrome and Related Disorders|October 14, 2010
Polycystic ovary syndrome in the pediatric populationAndrew A BremerMetabolic Syndrome and Related Disorders|October 14, 2010
Prevalence of hyperapolipoprotein B and associations with other cardiovascular risk factors among human immunodeficiency virus-infected patients in Pernambuco, BrazilErico Higino de Carvalho, Demócrito de Barros Miranda Filho, Ricardo Arraes de Alencar Ximenes, et al.Metabolic Syndrome and Related Disorders|December 7, 2010
Metformin treatment for small benign thyroid nodules in patients with insulin resistanceJorge Rezzónico, Mariana Rezzónico, Eduardo Pusiol, et al.Metabolic Syndrome and Related Disorders|July 27, 2011
Long chain omega-3 dietary supplements: a review of the National Library of Medicine Herbal Supplement DatabaseAtanaz Zargar, Matthew K ItoMetabolic Syndrome and Related Disorders|April 5, 2012
Apolipoproteins a-I and B as components of metabolic syndrome with respect to diabetes status: a factor analysisAlireza Esteghamati, Ali Zandieh, Abdoulreza Esteghamati, et al.Metabolic Syndrome and Related Disorders|December 14, 2011
General versus central adiposity and relationship to pediatric metabolic riskJason A Mendoza, Theresa A Nicklas, Yan Liu, et al.Metabolic Syndrome and Related Disorders|November 23, 2011
The insulin-like growth factor system, metabolic syndrome, and cardiovascular disease riskAbayomi O Akanji, Robert J SmithMetabolic Syndrome and Related Disorders|November 25, 2011
Association of serum lipoprotein-associated phospholipase A2 level with nonalcoholic fatty liver diseaseYasar Colak, Ebubekir Senates, Oguzhan Ozturk, et al.Pageof 141